Trials / Terminated
TerminatedNCT01148264
Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
Efficacy of Olanzapine in Break-through Emesis After Prophylaxis With Dexamethasone, 5-HT3 Receptor Antagonists and Aprepitant Compared to Metoclopramide
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Karin Jordan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is designed to evaluate olanzapine compared to the metoclopramide in the treatment of break through emesis after prophylaxis with dexamethasone, 5-HT 3 receptor antagonists and aprepitant in patients receiving chemotherapy. Efficacy will be assessed using a modified MASCC questionaire with a visual analog scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olanzapine | 1x10mg per day for three days |
| DRUG | metoclopramide | 3x10mg per day for three days |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2013-10-01
- Completion
- 2014-10-01
- First posted
- 2010-06-22
- Last updated
- 2016-05-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01148264. Inclusion in this directory is not an endorsement.